AlzPathway: a comprehensive map of signaling pathways of Alzheimer’s disease

Abstract

References 139

1. 1.

   Ballard C Gauthier S Corbett A Brayne C Aarsland D Jones E Alzheimer’s diseaseLancet2011 377977010191031

   Not in our library10.1016/s0140-6736(10)61349-9

2. 2.

   Ferri CP Prince M Brayne C Brodaty H Fratiglioni L Ganguli M Hall K Hasegawa K Hendrie H Huang Y Global prevalence of dementia: a Delphi consensus studyLancet2005 366950321122117

   Not in our library10.1016/s0140-6736(05)67889-0

3. 3.

   Alzheimer’s Disease InteranationalWorld Alzheimer’s Report 2010http://www.alz.co.uk/research/files/WorldAlzheimerReport2010ExecutiveSummary.pdf

   Not in our library

4. 4.

   Bertram L McQueen MB Mullin K Blacker D Tanzi RE Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene databaseNat Genet2007 3911723

   Not in our library10.1038/ng1934

5. 5.

   Bauer-Mehren A Furlong LI Sanz F Pathway databases and tools for their exploitation: benefits, current limitations and challengesMol Syst Biol2009 5290

   Not in our library10.1038/msb.2009.47

6. 6.

   Oda K Matsuoka Y Funahashi A Kitano H A comprehensive pathway map of epidermal growth factor receptor signalingMol Syst Biol2005 12005.0010

   Not in our library10.1038/msb4100014

7. 7.

   Oda K Kitano H A comprehensive map of the toll-like receptor signaling networkMol Syst Biol2006 22006.0015

   Not in our library10.1038/msb4100057

8. 8.

   Calzone L Gelay A Zinovyev A Radvanyi F Barillot E A comprehensive modular map of molecular interactions in RB/E2F pathwayMol Syst Biol2008 4173

   Not in our library10.1038/msb.2008.7

9. 9.

   Caron E Ghosh S Matsuoka Y Ashton-Beaucage D Therrien M Lemieux S Perreault C Roux PP Kitano H A comprehensive map of the mTOR signaling networkMol Syst Biol2010 6453

   Not in our library10.1038/msb.2010.108

10. 10.

    Patil S Pincas H Seto J Nudelman G Nudelman I Sealfon SC Signaling network of dendritic cells in response to pathogens: a community-input supported knowledgebaseBMC Syst Biol2010 4137

    Not in our library10.1186/1752-0509-4-137

11. 11.

    Funahashi A Matsuoka Y Jouraku A Morohashi M Kikuchi N Kitano H CellDesigner 3.5: a versatile modeling tool for biochemical networksProc IEEE2008 96812541265

    Not in our library

12. 12.

    Le Novère N Hucka M Mi H Moodie S Schreiber F Sorokin A Demir E Wegner K Aladjem MI Wimalaratne SM The Systems Biology Graphical NotationNat Biotechnol2009 278735741

    Not in our library10.1038/nbt.1558

13. 13.

    Hucka M Finney A Sauro HM Bolouri H Doyle JC Kitano H Arkin AP Bornstein BJ Bray D Cornish-Bowden A The systems biology markup language (SBML): a medium for representation and exchange of biochemical network modelsBioinformatics2003 194524531

    Not in our library10.1093/bioinformatics/btg015

14. 14.

    Laibe C Le Novère N MIRIAM Resources: tools to generate and resolve robust cross-references in Systems BiologyBMC Syst Biol2007 158

    Not in our library10.1186/1752-0509-1-58

15. 15.

    Matsuoka Y Ghosh S Kikuchi N Kitano H Payao: A community platform for SBML pathway model curationBioinformatics2010 261013811383

    Not in our library10.1093/bioinformatics/btq143

16. 16.

    Allain H Bentué-Ferrer D Tribut O Gauthier S Michel BF Drieu-La Rochelle C Alzheimer’s disease: the pharmacological pathwayFundam Clin Pharmacol2003 174419428

    Not in our library10.1046/j.1472-8206.2003.00153.x

17. 17.

    Arendt T Holzer M Stöbe A Gärtner U Lüth HJ Brückner MK Ueberham U Activated mitogenic signaling induces a process of dedifferentiation in Alzheimer’s disease that eventually results in cell deathAnn N Y Acad Sci2000 920249255

    Not in our library10.1111/j.1749-6632.2000.tb06931.x

18. 18.

    Atamna H Heme, iron, and the mitochondrial decay of ageingAgeing Res Rev2004 33303318

    Not in our library10.1016/j.arr.2004.02.002

19. 19.

    Behl C Apoptosis and Alzheimer’s diseaseJ Neural Transm2000 1071113251344

    Not in our library10.1007/s007020070021

20. 20.

    Björkhem I Crossing the barrier: oxysterols as cholesterol transporters and metabolic modulators in the brainJ Intern Med2006 2606493508

    Not in our library10.1111/j.1365-2796.2006.01725.x

21. 21.

    Boonen RA van Tijn P Zivkovic D Wnt signaling in Alzheimer’s disease: up or down, that is the questionAgeing Res Rev2009 827182

    Not in our library10.1016/j.arr.2008.11.003

22. 22.

    Bosco D Fava A Plastino M Montalcini T Pujia A Possible implications of insulin resistance and glucose metabolism in Alzheimer’s disease pathogenesisJ Cell Mol Med2011 15918071821

    Not in our library10.1111/j.1582-4934.2011.01318.x

23. 23.

    Brinton RD Estrogen regulation of glucose metabolism and mitochondrial function: therapeutic implications for prevention of Alzheimer’s diseaseAdv Drug Deliv Rev2008 6013–1415041511

    Not in our library10.1016/j.addr.2008.06.003

24. 24.

    Buhaescu I Izzedine H Mevalonate pathway: a review of clinical and therapeutical implicationsClin Biochem2007 409–10575584

    Not in our library10.1016/j.clinbiochem.2007.03.016

25. 25.

    Buoso E Lanni C Schettini G Govoni S Racchi M beta-Amyloid precursor protein metabolism: focus on the functions and degradation of its intracellular domainPharmacol Res2010 624308317

    Not in our library10.1016/j.phrs.2010.05.002

26. 26.

    Burns M Duff K Cholesterol in Alzheimer’s disease and tauopathyAnn N Y Acad Sci2002 977367375

    Not in our library10.1111/j.1749-6632.2002.tb04839.x

27. 27.

    Cameron B Landreth GE Inflammation, microglia, and Alzheimer’s diseaseNeurobiol Dis2010 373503509

    Not in our library10.1016/j.nbd.2009.10.006

28. 28.

    Caricasole A Bakker A Copani A Nicoletti F Gaviraghi G Terstappen GC Two sides of the same coin: Wnt signaling in neurodegeneration and neuro-oncologyBiosci Rep2005 255–6309327

    Not in our library10.1007/s10540-005-2893-6

29. 29.

    Caricasole A Copani A Caruso A Caraci F Iacovelli L Sortino MA Terstappen GC Nicoletti F The Wnt pathway, cell-cycle activation and beta-amyloid: novel therapeutic strategies in Alzheimer’s disease?Trends Pharmacol Sci2003 245233238

    Not in our library10.1016/s0165-6147(03)00100-7

30. 30.

    Chen YZ APP induces neuronal apoptosis through APP-BP1-mediated downregulation of beta-cateninApoptosis2004 94415422

    Not in our library10.1023/b:appt.0000031447.05354.9f

31. 31.

    Chong ZZ Li F Maiese K Stress in the brain: novel cellular mechanisms of injury linked to Alzheimer’s diseaseBrain Res Brain Res Rev2005 491121

    Not in our library10.1016/j.brainresrev.2004.11.005

32. 32.

    Chong ZZ Maiese K Targeting WNT, protein kinase B, and mitochondrial membrane integrity to foster cellular survival in the nervous systemHistol Histopathol2004 192495504

    Not in our library10.14670/hh-19.495

33. 33.

    Chorsky RL Yaghmai F Hill WD Stopa EG Alzheimer’s disease: a review concerning immune response and microischemiaMed Hypotheses2001 561124127

    Not in our library10.1054/mehy.2000.1148

34. 34.

    Choy YM Lau KM Lee CY Purification and characterization of urinary choriogonadotropin from patients with hydatidiform moleJ Biol Chem1979 254411591163

    Not in our library

35. 35.

    Copani A Caraci F Hoozemans JJ Calafiore M Sortino MA Nicoletti F The nature of the cell cycle in neurons: focus on a “non-canonical” pathway of DNA replication causally related to deathBiochim Biophys Acta2007 17724409412

    Not in our library10.1016/j.bbadis.2006.10.016

36. 36.

    Correia SC Santos RX Perry G Zhu X Moreira PI Smith MA Insulin-resistant brain state: the culprit in sporadic Alzheimer’s disease?Ageing Res Rev2011 102264273

    Not in our library10.1016/j.arr.2011.01.001

37. 37.

    Coughlan CM Breen KC Factors influencing the processing and function of the amyloid beta precursor protein–a potential therapeutic target in Alzheimer’s disease?Pharmacol Ther2000 862111145

    Not in our library10.1016/s0163-7258(00)00036-x

38. 38.

    Coulson EJ Does the p75 neurotrophin receptor mediate Abeta-induced toxicity in Alzheimer’s disease?J Neurochem2006 983654660

    Not in our library10.1111/j.1471-4159.2006.03905.x

39. 39.

    Cruts M Van Broeckhoven C Loss of progranulin function in frontotemporal lobar degenerationTrends Genet2008 244186194

    Not in our library10.1016/j.tig.2008.01.004

40. 40.

    Cuello AC Bruno MA The failure in NGF maturation and its increased degradation as the probable cause for the vulnerability of cholinergic neurons in Alzheimer’s diseaseNeurochem Res2007 32610411045

    Not in our library10.1007/s11064-006-9270-0

41. 41.

    Cuenda A Rousseau S p38 MAP-kinases pathway regulation, function and role in human diseasesBiochim Biophys Acta2007 1773813581375

    Not in our library10.1016/j.bbamcr.2007.03.010

42. 42.

    Das UN Acetylcholinesterase and butyrylcholinesterase as possible markers of low-grade systemic inflammationMed Sci Monit2007 1312RA214RA221

    Not in our library

43. 43.

    Deutsch SI Rosse RB Deutsch LH Faulty regulation of tau phosphorylation by the reelin signal transduction pathway is a potential mechanism of pathogenesis and therapeutic target in Alzheimer’s diseaseEur Neuropsychopharmacol2006 168547551

    Not in our library10.1016/j.euroneuro.2006.01.006

44. 44.

    Dmitriev LF Shortage of lipid-radical cycles in membranes as a possible prime cause of energetic failure in aging and Alzheimer diseaseNeurochem Res2007 32812781291

    Not in our library10.1007/s11064-007-9322-0

45. 45.

    Eckert A Keil U Marques CA Bonert A Frey C Schüssel K Müller WE Mitochondrial dysfunction, apoptotic cell death, and Alzheimer’s diseaseBiochem Pharmacol2003 66816271634

    Not in our library10.1016/s0006-2952(03)00534-3

46. 46.

    Eckert A Marques CA Keil U Schüssel K Müller WE Increased apoptotic cell death in sporadic and genetic Alzheimer’s diseaseAnn N Y Acad Sci2003 1010604609

    Not in our library10.1196/annals.1299.113

47. 47.

    Farooqui AA Ong WY Farooqui T Lipid mediators in the nucleus: Their potential contribution to Alzheimer’s diseaseBiochim Biophys Acta2010 18018906916

    Not in our library10.1016/j.bbalip.2010.02.002

48. 48.

    Filiz G Price KA Caragounis A Du T Crouch PJ White AR The role of metals in modulating metalloprotease activity in the AD brainEur Biophys J2008 373315321

    Not in our library10.1007/s00249-007-0244-1

49. 49.

    Florent-Béchard S Desbène C Garcia P Allouche A Youssef I Escanyé MC Koziel V Hanse M Malaplate-Armand C Stenger C The essential role of lipids in Alzheimer’s diseaseBiochimie2009 916804809

    Not in our library10.1016/j.biochi.2009.03.004

50. 50.

    Fraser PE Yang DS Yu G Lévesque L Nishimura M Arawaka S Serpell LC Rogaeva E St George-Hyslop P Presenilin structure, function and role in Alzheimer diseaseBiochim Biophys Acta2000 15021115

    Not in our library10.1016/s0925-4439(00)00028-4

51. 51.

    Fuentealba RA Farias G Scheu J Bronfman M Marzolo MP Inestrosa NC Signal transduction during amyloid-beta-peptide neurotoxicity: role in Alzheimer diseaseBrain Res Brain Res Rev2004 471–3275289

    Not in our library10.1016/j.brainresrev.2004.07.018

52. 52.

    Gandy S The role of cerebral amyloid beta accumulation in common forms of Alzheimer diseaseJ Clin Invest2005 115511211129

    Not in our library10.1172/jci25100

53. 53.

    Gärtner U Holzer M Arendt T Elevated expression of p21ras is an early event in Alzheimer’s disease and precedes neurofibrillary degenerationNeuroscience1999 91115

    Not in our library10.1016/s0306-4522(99)00059-7

54. 54.

    Gasparini L Xu H Potential roles of insulin and IGF-1 in Alzheimer’s diseaseTrends Neurosci2003 268404406

    Not in our library10.1016/s0166-2236(03)00163-2

55. 55.

    Ghosh AK Gemma S Tang J beta-Secretase as a therapeutic target for Alzheimer’s diseaseNeurotherapeutics2008 53399408

    Not in our library10.1016/j.nurt.2008.05.007

56. 56.

    Glass CK Saijo K Winner B Marchetto MC Gage FH Mechanisms underlying inflammation in neurodegenerationCell2010 1406918934

    Not in our library10.1016/j.cell.2010.02.016

57. 57.

    Goodenough S Schäfer M Behl C Estrogen-induced cell signalling in a cellular model of Alzheimer’s diseaseJ Steroid Biochem Mol Biol2003 842–3301305

    Not in our library10.1016/s0960-0760(03)00043-8

58. 58.

    Halliday G Robinson SR Shepherd C Kril J Alzheimer’s disease and inflammation: a review of cellular and therapeutic mechanismsClin Exp Pharmacol Physiol2000 271–218

    Not in our library10.1046/j.1440-1681.2000.03200.x

59. 59.

    Hamaguchi T Ono K Yamada M Anti-amyloidogenic therapies: strategies for prevention and treatment of Alzheimer’s diseaseCell Mol Life Sci2006 631315381552

    Not in our library10.1007/s00018-005-5599-9

60. 60.

    Hamdane M Delobel P Sambo AV Smet C Bégard S Violleau A Landrieu I Delacourte A Lippens G Flament S Neurofibrillary degeneration of the Alzheimer-type: an alternate pathway to neuronal apoptosis?Biochem Pharmacol2003 66816191625

    Not in our library10.1016/s0006-2952(03)00533-1

61. 61.

    Harold D Abraham R Hollingworth P Sims R Gerrish A Hamshere ML Pahwa JS Moskvina V Dowzell K Williams A Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer’s diseaseNat Genet2009 411010881093

    Not in our library10.1038/ng.440

62. 62.

    Hartmann D Tournoy J Saftig P Annaert W De Strooper B Implication of APP secretases in notch signalingJ Mol Neurosci2001 172171181

    Not in our library10.1385/jmn:17:2:171

63. 63.

    Hartmann T Intracellular biology of Alzheimer’s disease amyloid beta peptideEur Arch Psychiatry Clin Neurosci1999 2496291298

    Not in our library10.1007/s004060050102

64. 64.

    Hegde AN Upadhya SC The ubiquitin-proteasome pathway in health and disease of the nervous systemTrends Neurosci2007 3011587595

    Not in our library10.1016/j.tins.2007.08.005

65. 65.

    Hicks D John D Makova NZ Henderson Z Nalivaeva NN Turner AJ Membrane targeting, shedding and protein interactions of brain acetylcholinesteraseJ Neurochem2011 1165742746

    Not in our library10.1111/j.1471-4159.2010.07032.x

66. 66.

    Hölscher C Li L New roles for insulin-like hormones in neuronal signalling and protection: new hopes for novel treatments of Alzheimer’s disease?Neurobiol Aging2010 31914951502

    Not in our library10.1016/j.neurobiolaging.2008.08.023

67. 67.

    Hooper NM Roles of proteolysis and lipid rafts in the processing of the amyloid precursor protein and prion proteinBiochem Soc Trans2005 33Pt 2335338

    Not in our library10.1042/bst0330335

68. 68.

    Inestrosa NC Varela-Nallar L Grabowski CP Colombres M Synaptotoxicity in Alzheimer’s disease: the Wnt signaling pathway as a molecular targetIUBMB Life2007 594–5316321

    Not in our library10.1080/15216540701242490

69. 69.

    Issad T Masson E Pagesy P O-GlcNAc modification, insulin signaling and diabetic complicationsDiabetes Metab2010 366 Pt 1423435

    Not in our library10.1016/j.diabet.2010.09.001

70. 70.

    Iwata N Saido TC Amyloid-beta peptide metabolism and Alzheimer’s diseaseNihon Yakurigaku Zasshi2003 1221514

    Not in our library10.1254/fpj.122.5

71. 71.

    Johnson GV Bailey CD The p38 MAP kinase signaling pathway in Alzheimer’s diseaseExp Neurol2003 1832263268

    Not in our library10.1016/s0014-4886(03)00268-1

72. 72.

    Kamoun P Endogenous production of hydrogen sulfide in mammalsAmino Acids2004 263243254

    Not in our library10.1007/s00726-004-0072-x

73. 73.

    Katayama T Imaizumi K Manabe T Hitomi J Kudo T Tohyama M Induction of neuronal death by ER stress in Alzheimer’s diseaseJ Chem Neuroanat2004 281–26778

    Not in our library10.1016/j.jchemneu.2003.12.004

74. 74.

    Kim D Tsai LH Bridging physiology and pathology in ADCell2009 13769971000

    Not in our library10.1016/j.cell.2009.05.042

75. 75.

    Klysik J Theroux SJ Sedivy JM Moffit JS Boekelheide K Signaling crossroads: the function of Raf kinase inhibitory protein in cancer, the central nervous system and reproductionCell Signal2008 20119

    Not in our library10.1016/j.cellsig.2007.07.003

76. 76.

    Kontush A Amyloid-beta: an antioxidant that becomes a pro-oxidant and critically contributes to Alzheimer’s diseaseFree Radic Biol Med2001 31911201131

    Not in our library10.1016/s0891-5849(01)00688-8

77. 77.

    Kopan R Goate A Aph-2/Nicastrin: an essential component of gamma-secretase and regulator of Notch signaling and Presenilin localizationNeuron2002 333321324

    Not in our library10.1016/s0896-6273(02)00585-8

78. 78.

    Layfield R Alban A Mayer RJ Lowe J The ubiquitin protein catabolic disordersNeuropathol Appl Neurobiol2001 273171179

    Not in our library10.1046/j.1365-2990.2001.00335.x

79. 79.

    Lee CY Landreth GE The role of microglia in amyloid clearance from the AD brainJ Neural Transm2010 1178949960

    Not in our library10.1007/s00702-010-0433-4

80. 80.

    Lefebvre T Dehennaut V Guinez C Olivier S Drougat L Mir AM Mortuaire M Vercoutter-Edouart AS Michalski JC Dysregulation of the nutrient/stress sensor O-GlcNAcylation is involved in the etiology of cardiovascular disorders, type-2 diabetes and Alzheimer’s diseaseBiochim Biophys Acta2010 180026779

    Not in our library10.1016/j.bbagen.2009.08.008

81. 81.

    Li H Wolfe MS Selkoe DJ Toward structural elucidation of the gamma-secretase complexStructure2009 173326334

    Not in our library10.1016/j.str.2009.01.007

82. 82.

    Mahley RW Ji ZS Remnant lipoprotein metabolism: key pathways involving cell-surface heparan sulfate proteoglycans and apolipoprotein EJ Lipid Res1999 401116

    Not in our library

83. 83.

    Mariño G López-Otín C Autophagy: molecular mechanisms, physiological functions and relevance in human pathologyCell Mol Life Sci2004 611214391454

    Not in our library10.1007/s00018-004-4012-4

84. 84.

    Masters CL Beyreuther K Alzheimer’s centennial legacy: prospects for rational therapeutic intervention targeting the Abeta amyloid pathwayBrain2006 129Pt 1128232839

    Not in our library10.1093/brain/awl251

85. 85.

    Mattson MP Cellular actions of beta-amyloid precursor protein and its soluble and fibrillogenic derivativesPhysiol Rev1997 77410811132

    Not in our library10.1152/physrev.1997.77.4.1081

86. 86.

    Mattson MP Chan SL Camandola S Presenilin mutations and calcium signaling defects in the nervous and immune systemsBioessays2001 238733744

    Not in our library10.1002/bies.1103

87. 87.

    McGeer PL McGeer EG Anti-inflammatory drugs in the fight against Alzheimer’s diseaseAnn N Y Acad Sci1996 777213220

    Not in our library10.1111/j.1749-6632.1996.tb34421.x

88. 88.

    McLoughlin DM Miller CC The FE65 proteins and Alzheimer’s diseaseJ Neurosci Res2008 864744754

    Not in our library10.1002/jnr.21532

89. 89.

    McTaggart SJ Isoprenylated proteinsCell Mol Life Sci2006 633255267

    Not in our library10.1007/s00018-005-5298-6

90. 90.

    Mischoulon D Fava M Role of S-adenosyl-L-methionine in the treatment of depression: a review of the evidenceAm J Clin Nutr2002 7651158S1161S

    Not in our library10.1093/ajcn/76/5.1158s

91. 91.

    Moley KH Mueckler MM Glucose transport and apoptosisApoptosis2000 5299105

    Not in our library10.1023/a:1009697908332

92. 92.

    Morgan C Colombres M Nuñez MT Inestrosa NC Structure and function of amyloid in Alzheimer’s diseaseProg Neurobiol2004 746323349

    Not in our library10.1016/j.pneurobio.2004.10.004

93. 93.

    Nagai Y Ogasawara A Heese K Possible mechanisms of A beta(1–40)- or A beta(1–42)-induced cell death and their rescue factorsNihon Yakurigaku Zasshi2004 1243135143

    Not in our library10.1254/fpj.124.135

94. 94.

    Nelson TJ Alkon DL Insulin and cholesterol pathways in neuronal function, memory and neurodegenerationBiochem Soc Trans2005 33Pt 510331036

    Not in our library10.1042/bst20051033

95. 95.

    Nixon RA A “protease activation cascade” in the pathogenesis of Alzheimer’s diseaseAnn N Y Acad Sci2000 924117131

    Not in our library

96. 96.

    Pascale A Amadio M Govoni S Battaini F The aging brain, a key target for the future: the protein kinase C involvementPharmacol Res2007 556560569

    Not in our library10.1016/j.phrs.2007.04.013

97. 97.

    Poirier J Apolipoprotein E and Alzheimer’s diseaseA role in amyloid catabolism. Ann N Y Acad Sci2000 9248190

    Not in our library10.1111/j.1749-6632.2000.tb05564.x

98. 98.

    Poirier J Apolipoprotein E, cholesterol transport and synthesis in sporadic Alzheimer’s diseaseNeurobiol Aging2005 263355361

    Not in our library10.1016/j.neurobiolaging.2004.09.003

99. 99.

    Puglielli L Aging of the brain, neurotrophin signaling, and Alzheimer’s disease: is IGF1-R the common culprit?Neurobiol Aging2008 296795811

    Not in our library10.1016/j.neurobiolaging.2007.01.010

100. 100.

     Reid PC Urano Y Kodama T Hamakubo T Alzheimer’s disease: cholesterol, membrane rafts, isoprenoids and statinsJ Cell Mol Med2007 113383392

     Not in our library10.1111/j.1582-4934.2007.00054.x

101. 101.

     Rogers JT Bush AI Cho HH Smith DH Thomson AM Friedlich AL Lahiri DK Leedman PJ Huang X Cahill CM Iron and the translation of the amyloid precursor protein (APP) and ferritin mRNAs: riboregulation against neural oxidative damage in Alzheimer’s diseaseBiochem Soc Trans2008 36Pt 612821287

     Not in our library10.1042/bst0361282

102. 102.

     Rojo LE Fernández JA Maccioni AA Jimenez JM Maccioni RB Neuroinflammation: implications for the pathogenesis and molecular diagnosis of Alzheimer’s diseaseArch Med Res2008 391116

     Not in our library10.1016/j.arcmed.2007.10.001

103. 103.

     Rosner M Hanneder M Siegel N Valli A Fuchs C Hengstschläger M The mTOR pathway and its role in human genetic diseasesMutat Res2008 6593284292

     Not in our library10.1016/j.mrrev.2008.06.001

104. 104.

     Rossner S New players in old amyloid precursor protein-processing pathwaysInt J Dev Neurosci2004 227467474

     Not in our library10.1016/j.ijdevneu.2004.07.004

105. 105.

     Rossner S Ueberham U Schliebs R Perez-Polo JR Bigl V The regulation of amyloid precursor protein metabolism by cholinergic mechanisms and neurotrophin receptor signalingProg Neurobiol1998 565541569

     Not in our library10.1016/s0301-0082(98)00044-6

106. 106.
     Lipid Rafts: Linking Alzheimer′s Amyloid‐ β Production, Aggregation, and Toxicity at Neuronal Membranes · 2010

     No notice
107. 107.

     Salminen A Ojala J Kauppinen A Kaarniranta K Suuronen T Inflammation in Alzheimer’s disease: amyloid-beta oligomers trigger innate immunity defence via pattern recognition receptorsProg Neurobiol2009 873181194

     Not in our library10.1016/j.pneurobio.2009.01.001

108. 108.

     Schöneich C Methionine oxidation by reactive oxygen species: reaction mechanisms and relevance to Alzheimer’s diseaseBiochim Biophys Acta2005 17032111119

     Not in our library10.1016/j.bbapap.2004.09.009

109. 109.

     Selkoe DJ Notch and presenilins in vertebrates and invertebrates: implications for neuronal development and degenerationCurr Opin Neurobiol2000 1015057

     Not in our library10.1016/s0959-4388(99)00054-9

110. 110.

     Selkoe D Kopan R Notch and Presenilin: regulated intramembrane proteolysis links development and degenerationAnnu Rev Neurosci2003 26565597

     Not in our library10.1146/annurev.neuro.26.041002.131334

111. 111.

     Sinha S Lieberburg I Cellular mechanisms of beta-amyloid production and secretionProc Natl Acad Sci U S A1999 96201104911053

     Not in our library10.1073/pnas.96.20.11049

112. 112.

     Small SA Retromer sorting: a pathogenic pathway in late-onset Alzheimer diseaseArch Neurol2008 653323328

     Not in our library10.1001/archneurol.2007.64

113. 113.

     Small SA Duff K Linking Abeta and tau in late-onset Alzheimer’s disease: a dual pathway hypothesisNeuron2008 604534542

     Not in our library10.1016/j.neuron.2008.11.007

114. 114.

     Soreghan B Thomas SN Yang AJ Aberrant sphingomyelin/ceramide metabolic-induced neuronal endosomal/lysosomal dysfunction: potential pathological consequences in age-related neurodegenerationAdv Drug Deliv Rev2003 551115151524

     Not in our library10.1016/j.addr.2003.07.007

115. 115.

     Stark DT Bazan NG Neuroprotectin D1 induces neuronal survival and downregulation of amyloidogenic processing in Alzheimer’s disease cellular modelsMol Neurobiol2011 432131138

     Not in our library10.1007/s12035-011-8174-4

116. 116.

     Tafti M Ghyselinck NB Functional implication of the vitamin A signaling pathway in the brainArch Neurol2007 641217061711

     Not in our library10.1001/archneur.64.12.1706

117. 117.

     Takashima A Drug development targeting the glycogen synthase kinase-3beta (GSK-3beta)-mediated signal transduction pathway: role of GSK-3beta in adult brainJ Pharmacol Sci2009 1092174178

     Not in our library10.1254/jphs.08r29fm

118. 118.

     Takatori Y Mechanisms of neuroprotective effects of therapeutic acetylcholinesterase inhibitors used in treatment of Alzheimer’s diseaseYakugaku Zasshi2006 1268607616

     Not in our library10.1248/yakushi.126.607

119. 119.

     Toledo EM Colombres M Inestrosa NC Wnt signaling in neuroprotection and stem cell differentiationProg Neurobiol2008 863281296

     Not in our library10.1016/j.pneurobio.2008.08.001

120. 120.

     Townsend KP Obregon D Quadros A Patel N Volmar C Paris D Mullan M Proinflammatory and vasoactive effects of Abeta in the cerebrovasculatureAnn N Y Acad Sci2002 9776576

     Not in our library10.1111/j.1749-6632.2002.tb04799.x

121. 121.

     Turner PR O’Connor K Tate WP Abraham WC Roles of amyloid precursor protein and its fragments in regulating neural activity, plasticity and memoryProg Neurobiol2003 701132

     Not in our library10.1016/s0301-0082(03)00089-3

122. 122.

     Uthayathas S Karuppagounder SS Thrash BM Parameshwaran K Suppiramaniam V Dhanasekaran M Versatile effects of sildenafil: recent pharmacological applicationsPharmacol Rep2007 592150163

     Not in our library

123. 123.

     Van Nostrand WE Melchor J Wagner M Davis J Cerebrovascular smooth muscle cell surface fibrillar A beta. Alteration of the proteolytic environment in the cerebral vessel wallAnn N Y Acad Sci2000 9038996

     Not in our library10.1111/j.1749-6632.2000.tb06354.x

124. 124.

     Vasto S Candore G Listì F Balistreri CR Colonna-Romano G Malavolta M Lio D Nuzzo D Mocchegiani E Di Bona D Inflammation, genes and zinc in Alzheimer’s diseaseBrain Res Rev2008 58196105

     Not in our library10.1016/j.brainresrev.2007.12.001

125. 125.

     Vetrivel KS Thinakaran G Membrane rafts in Alzheimer’s disease beta-amyloid productionBiochim Biophys Acta2010 18018860867

     Not in our library10.1016/j.bbalip.2010.03.007

126. 126.

     Wang LH Besirli CG Johnson EM Mixed-lineage kinases: a target for the prevention of neurodegenerationAnnu Rev Pharmacol Toxicol2004 44451474

     Not in our library10.1146/annurev.pharmtox.44.101802.121840

127. 127.

     Weggen S Rogers M Eriksen J NSAIDs: small molecules for prevention of Alzheimer’s disease or precursors for future drug development?Trends Pharmacol Sci2007 2810536543

     Not in our library10.1016/j.tips.2007.09.004

128. 128.

     Wei J Bhattacharyya S Varga J Peroxisome proliferator-activated receptor γ: innate protection from excessive fibrogenesis and potential therapeutic target in systemic sclerosisCurr Opin Rheumatol2010 226671676

     Not in our library10.1097/bor.0b013e32833de1a7

129. 129.

     Wellington CL Hayden MR Caspases and neurodegeneration: on the cutting edge of new therapeutic approachesClin Genet2000 571110

     Not in our library10.1034/j.1399-0004.2000.570101.x

130. 130.

     Woodgett JR Judging a protein by more than its name: GSK-3Sci STKE2001 2001100re12

     Not in our library10.1126/stke.2001.100.re12

131. 131.

     Wu HY Tomizawa K Matsui H Calpain-calcineurin signaling in the pathogenesis of calcium-dependent disorderActa Med Okayama2007 613123137

     Not in our library10.18926/amo/32905

132. 132.

     Wyss-Coray T Rogers J Inflammation in Alzheimer Disease−−A Brief Review of the Basic Science and Clinical LiteratureCold Spring Harbor Perspect Med2012 21a006346

     Not in our library10.1101/cshperspect.a006346

133. 133.

     Yamamoto Y Gaynor RB Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancerJ Clin Invest2001 1072135142

     Not in our library10.1172/jci11914

134. 134.

     Yang SY He XY Miller D HSD17B10: a gene involved in cognitive function through metabolism of isoleucine and neuroactive steroidsMol Genet Metab2007 921–23642

     Not in our library10.1016/j.ymgme.2007.06.001

135. 135.

     Yoshimura T Arimura N Kaibuchi K Molecular mechanisms of axon specification and neuronal disordersAnn N Y Acad Sci2006 1086116125

     Not in our library10.1196/annals.1377.013

136. 136.

     Zhao WQ Townsend M Insulin resistance and amyloidogenesis as common molecular foundation for type 2 diabetes and Alzheimer’s diseaseBiochim Biophys Acta2009 17925482496

     Not in our library10.1016/j.bbadis.2008.10.014

137. 137.

     Zipp F Waiczies S Aktas O Neuhaus O Hemmer B Schraven B Nitsch R Hartung HP Impact of HMG-CoA reductase inhibition on brain pathologyTrends Pharmacol Sci2007 287342349

     Not in our library10.1016/j.tips.2007.05.001

138. 138.

     Zlokovic BV New therapeutic targets in the neurovascular pathway in Alzheimer’s diseaseNeurotherapeutics2008 53409414

     Not in our library10.1016/j.nurt.2008.05.011

139. 139.

     Smoot ME Ono K Ruscheinski J Wang PL Ideker T Cytoscape 2.8: new features for data integration and network visualizationBioinformatics2011 273431432

     Not in our library10.1093/bioinformatics/btq675

Cited by papers we hold 5

• Alzheimer’s Disease: An Update and Insights Into Pathophysiology · 2022
  No notice
• LimeMap: a comprehensive map of lipid mediator metabolic pathways · 2021
  Not checked
• A logical network-based drug-screening platform for Alzheimer’s disease representing pathological features of human brain organoids · 2021
  No notice
• Machine learning identifies candidates for drug repurposing in Alzheimer’s disease · 2021
  No notice
• The central role of AMP-kinase and energy homeostasis impairment in Alzheimer's disease: a multifactor network analysis. · 2013
  Not checked

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.